Iván R. González on a paper by Marjorie E. Zettler

Iván R. González, Medical Oncologist at Comprehensive Oncology Center, Hospital Ángeles Puebla, shared a post on X:

“Optimizing cancer therapy dosages is essential!

Targeted therapies have slashed cancer mortality and set a new standard, but traditional dosing methods lag behind. The FDA’s Project Optimus and new guidelines aim to fix this. Reshaping pre-approval dosing and continuous research will maximize patient benefits and minimize avoidable toxicity.

Future incentives for post-market dose optimization could be a game-changer.”

Read further
Source: Iván R. González/X